Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etamsylate for Postpancreatectomy Hemorrhage in Pancreatogastrostomy
NCT06190535Not yet recruiting
- Sponsor
- University of Sfax
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of etamsylate in Postpancreatectomy hemorrhage (PPH) (2 arms), sponsored by University of Sfax. Primary endpoint: Rate of postoperative early (24-48 hours) digestive hemorrhage. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
etamsylate
03
Conditions
Postpancreatectomy hemorrhage (PPH)
Beyond the preview
Go deeper on NCT06190535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06190535.